Literature DB >> 18709301

Inflammation and hypercoagulable state in adult psoriatic men.

Ozlem Karabudak1, Rifat Eralp Ulusoy, Alev Akyol Erikci, Emrullah Solmazgul, Bilal Dogan, Yavuz Harmanyeri.   

Abstract

Hyperhomocysteinaemia is a well-known risk factor for cardiovascular disease and plays a role in atherothrombosis. Psoriasis is a common chronic and recurrent inflammatory skin disease associated with increased thrombosis. The aim of this study was to examine serum homocysteine levels and their relationships with inflammatory and atherothrombotic markers in psoriasis. Twenty patients with mild or moderate psoriasis and 20 age-matched healthy men were included in this study. Patients with acquired hyperhomocysteinaemia were excluded from both groups. The inflammation markers, mean platelet volume, C-reactive protein and ceruloplasmin levels, were significantly increased in the study group compared with the control group. In the study group there was decreased antithrombin III and total homocysteine levels, for haemostatic parameters. Folic acid levels, cardiovascular risk factors, endothelial inflammation markers and blood coagulation factors demonstrated significant correlations. Folic acid levels correlated inversely with homocysteine and positively with fibrinogen levels. In conclusion, increased homocysteine concentration and inflammation markers may play a role in the atherothrombotic state in psoriasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18709301     DOI: 10.2340/00015555-0456

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  17 in total

1.  Methylenetetrahydrofolate reductase (MTHFR) 677C>T gene polymorphism as a possible factor for reducing clinical severity of psoriasis.

Authors:  Ercan Karabacak; Ersin Aydin; Omer Ozcan; Bilal Dogan; Mustafa Gultepe; Alpaslan Cosar; Tuba Muftuoglu
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 2.  Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.

Authors:  Rita V Patel; Michael L Shelling; Srdjan Prodanovich; Daniel G Federman; Robert S Kirsner
Journal:  J Gen Intern Med       Date:  2011-04-07       Impact factor: 5.128

Review 3.  The association between platelet indices and presence and severity of psoriasis: a systematic review and meta-analysis.

Authors:  Z Liu; L A Perry; V Morgan
Journal:  Clin Exp Med       Date:  2022-04-04       Impact factor: 3.984

Review 4.  Psoriasis.

Authors:  Paola Di Meglio; Federica Villanova; Frank O Nestle
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

5.  Noninvasive assessment of impaired endothelial function in psoriasis.

Authors:  Rifat Eralp Ulusoy; Ozlem Karabudak; Mehmet Yokusoglu; Fethi Kilicaslan; Ata Kirilmaz; Bekir Sitki Cebeci
Journal:  Rheumatol Int       Date:  2009-06-16       Impact factor: 2.631

6.  Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study.

Authors:  Ole Ahlehoff; Gunnar Hilmar Gislason; Jesper Lindhardsen; Mette Gitz Charlot; Casper Haslund Jørgensen; Jonas Bjerring Olesen; Ditte-Marie Bretler; Lone Skov; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

7.  Portal vein thrombosis associated with psoriasis: a case report.

Authors:  Jevon M Yudhishdran; Rayno Navinan; Sivakumar Jeyalakshmy; Ashoka Ratnatilaka
Journal:  BMC Res Notes       Date:  2015-03-18

8.  A Correlative Study between Platelet Count, Mean Platelet Volume and Red Cell Distribution Width with the Disease Severity Index in Psoriasis Patients.

Authors:  Vijayashree Raghavan; Rajesh Kanna Nandagopal Radha; Ramesh K Rao; Abinaya Kuberan
Journal:  J Clin Diagn Res       Date:  2017-09-01

9.  Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis.

Authors:  Arzu Ataseven; Recep Kesli; Gulcan Saylam Kurtipek; Perihan Ozturk
Journal:  Dis Markers       Date:  2014-04-02       Impact factor: 3.434

10.  Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity.

Authors:  Janette Bester; Etheresia Pretorius
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.